Treatment of osteonecrosis of the jaw related to bisphosphonates and other antiresorptive agents

BACKGROUND: The clinical management of medication-related osteonecrosis of the jaw (MRONJ) in patients treated with bisphosphonates and other antiresorptive agents is subject to controversy. The American Association of Oral and Maxillofacial Surgeons (AAOMS) has developed guidelines for the correct...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodriguez-Lozano, Francisco-Javier, Oñate-Sánchez, Ricardo-Elías
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medicina Oral S.L. 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005097/
https://www.ncbi.nlm.nih.gov/pubmed/27475683
http://dx.doi.org/10.4317/medoral.20980

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005097/
https://www.ncbi.nlm.nih.gov/pubmed/27475683
http://dx.doi.org/10.4317/medoral.20980

Ejemplares similares